Cargando…

Plant Molecular Farming: A Viable Platform for Recombinant Biopharmaceutical Production

The demand for recombinant proteins in terms of quality, quantity, and diversity is increasing steadily, which is attracting global attention for the development of new recombinant protein production technologies and the engineering of conventional established expression systems based on bacteria or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shanmugaraj, Balamurugan, I. Bulaon, Christine Joy, Phoolcharoen, Waranyoo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411908/ https://www.ncbi.nlm.nih.gov/pubmed/32635427 http://dx.doi.org/10.3390/plants9070842

Ejemplares similares

Biotechnological Insights on the Expression and Production of Antimicrobial Peptides in Plants
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2021)

Harnessing the Potential of Plant Expression System towards the Production of Vaccines for the Prevention of Human Papillomavirus and Cervical Cancer
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2022)

Plant-produced SARS-CoV-2 receptor binding domain (RBD) variants showed differential binding efficiency with anti-spike specific monoclonal antibodies
por: Rattanapisit, Kaewta, et al.
Publicado: (2021)

Rapid transient expression of functional human vascular endothelial growth factor in Nicotiana benthamiana and characterization of its biological activity
por: Bulaon, Christine Joy I., et al.
Publicado: (2020)

Development of SARS-CoV-2 neutralizing antibody detection assay by using recombinant plant-produced proteins
por: Jirarojwattana, Perawat, et al.
Publicado: (2023)

Potential for Developing Plant-Derived Candidate Vaccines and Biologics against Emerging Coronavirus Infections
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2021)

Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2020)

In vitro and in vivo studies of plant-produced Atezolizumab as a potential immunotherapeutic antibody
por: Rattanapisit, Kaewta, et al.
Publicado: (2023)

Efficiency Comparative Approach of Plant-Produced Monoclonal Antibodies against Rabies Virus Infection
por: Lumlertdacha, Boonlert, et al.
Publicado: (2023)

Plant-produced recombinant SARS-CoV-2 receptor-binding domain; an economical, scalable biomaterial source for COVID-19 diagnosis
por: Rattanapisit, Kaewta, et al.
Publicado: (2021)

Functional Characterization of Pembrolizumab Produced in Nicotiana benthamiana Using a Rapid Transient Expression System
por: Phakham, Tanapati, et al.
Publicado: (2021)

SARS‐CoV‐2 omicron variant: Could it be another threat?
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2022)

Immunogenicity and efficacy of recombinant subunit SARS-CoV-2 vaccine candidate in the Syrian hamster model
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2022)

Expression and Functional Evaluation of Recombinant Anti-receptor Activator of Nuclear Factor Kappa-B Ligand Monoclonal Antibody Produced in Nicotiana benthamiana
por: Boonyayothin, Wanuttha, et al.
Publicado: (2021)

Monoclonal Antibodies B38 and H4 Produced in Nicotiana benthamiana Neutralize SARS-CoV-2 in vitro
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2020)

Feasibility of plant-expression system for production of recombinant anti-human IgE: An alternative production platform for therapeutic monoclonal antibodies
por: Hanittinan, Oranicha, et al.
Publicado: (2022)

Development of Plant-Produced Recombinant ACE2-Fc Fusion Protein as a Potential Therapeutic Agent Against SARS-CoV-2
por: Siriwattananon, Konlavat, et al.
Publicado: (2021)

Expression optimization, purification and in vitro characterization of human epidermal growth factor produced in Nicotiana benthamiana
por: Hanittinan, Oranicha, et al.
Publicado: (2020)

Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants
por: Daniell, Henry, et al.
Publicado: (2001)

Antitumor effect of plant-produced anti-CTLA-4 monoclonal antibody in a murine model of colon cancer
por: Bulaon, Christine Joy I., et al.
Publicado: (2023)

A recombinant subunit vaccine candidate produced in plants elicits neutralizing antibodies against SARS-CoV-2 variants in macaques
por: Khorattanakulchai, Narach, et al.
Publicado: (2022)

Artificial intelligence-driven systems engineering for next-generation plant-derived biopharmaceuticals
por: Parthiban, Subramanian, et al.
Publicado: (2023)

Plant-Produced S1 Subunit Protein of SARS-CoV-2 Elicits Immunogenic Responses in Mice
por: Panapitakkul, Chalisa, et al.
Publicado: (2022)

Editorial: Plant-Production Platforms for Veterinary Biopharmaceuticals
por: Baschieri, Selene, et al.
Publicado: (2022)

Yeasts as Biopharmaceutical Production Platforms
por: Kulagina, Natalja, et al.
Publicado: (2021)

Plant-produced recombinant Osteopontin-Fc fusion protein enhanced osteogenesis
por: Rattanapisit, Kaewta, et al.
Publicado: (2019)

Utilization of Site-Specific Recombination in Biopharmaceutical Production
por: Ahmadi, Maryam, et al.
Publicado: (2016)

Immunogenicity Studies of Plant-Produced SARS-CoV-2 Receptor Binding Domain-Based Subunit Vaccine Candidate with Different Adjuvant Formulations
por: Siriwattananon, Konlavat, et al.
Publicado: (2021)

Preclinical evaluation of immunogenicity, efficacy and safety of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3M-052-Alum adjuvant
por: Phoolcharoen, Waranyoo, et al.
Publicado: (2023)

Development of Systems for the Production of Plant-Derived Biopharmaceuticals
por: Moon, Ki-Beom, et al.
Publicado: (2019)

Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana
por: Rattanapisit, Kaewta, et al.
Publicado: (2020)

Electrochemical paper-based antigen sensing platform using plant-derived monoclonal antibody for detecting SARS-CoV-2
por: Jaewjaroenwattana, Jutamas, et al.
Publicado: (2023)

Development of a plant-produced recombinant monoclonal antibody against Δ-9-tetrahydrocannabinol (Δ9-THC) for immunoassay application
por: Boonyayothin, Wanuttha, et al.
Publicado: (2022)

Efficient Transient Expression of Recombinant Proteins Using DNA Viral Vectors in Freshwater Microalgal Species
por: Malla, Ashwini, et al.
Publicado: (2021)

Plant-based biopharmaceutical engineering
por: Eidenberger, Lukas, et al.
Publicado: (2023)

Perspectives for Glyco-Engineering of Recombinant Biopharmaceuticals from Microalgae
por: Barolo, Lorenzo, et al.
Publicado: (2020)

Plant molecular farming: systems and products
por: Horn, M. E., et al.
Publicado: (2004)

A Brief Reminder of Systems of Production and Chromatography-Based Recovery of Recombinant Protein Biopharmaceuticals
por: Owczarek, B., et al.
Publicado: (2019)

Enzyme-linked immunosorbent assay for the quantitative/qualitative analysis of plant secondary metabolites
por: Sakamoto, Seiichi, et al.
Publicado: (2017)

Cyberbiosecurity for Biopharmaceutical Products
por: Mantle, Jennifer L., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2vvoujpgp3gkftc7a34vs79jin